Canadian Sec - Delayed Quote CAD
Doseology Sciences Inc. (MOOD.CN)
At close: October 18 at 12:40 PM EDT
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
104.2850
43.0880
16.0480
--
--
Cost of Revenue
14.6670
1.8020
164.4270
--
--
Gross Profit
89.6180
41.2860
-148.3790
--
--
Operating Expense
453.0970
873.4590
1,668.2630
1,567.2770
431.6320
Operating Income
-363.4790
-832.1730
-1,816.6420
-1,567.2770
-431.6320
Net Non Operating Interest Income Expense
48.8480
28.9040
-68.9380
-65.2800
--
Other Income Expense
-965.9350
-978.2750
-53.7410
6.0000
--
Pretax Income
-1,280.5660
-1,781.5440
-1,939.3210
-1,626.5570
-431.6320
Net Income Common Stockholders
-1,377.3260
-1,781.5440
-1,939.3210
-1,626.5570
-431.6320
Diluted NI Available to Com Stockholders
-1,377.3260
-1,781.5440
-1,939.3210
-1,626.5570
-431.6320
Basic EPS
-0.25
-0.40
-0.50
-0.40
-0.11
Diluted EPS
-0.25
-0.40
-0.50
-0.40
-0.11
Basic Average Shares
4,489.1440
4,110.0300
3,909.7070
4,100.0000
4,100.0000
Diluted Average Shares
4,489.1440
4,110.0300
3,909.7070
4,100.0000
4,100.0000
Rent Expense Supplemental
--
17.1880
31.4810
92.1180
62.2100
Total Expenses
467.7640
875.2610
1,832.6900
1,567.2770
431.6320
Net Income from Continuing & Discontinued Operation
-1,377.3260
-1,781.5440
-1,939.3210
-1,626.5570
-431.6320
Normalized Income
-423.6220
-803.2690
-1,885.5800
-1,632.5570
-431.6320
Interest Income
30.3050
65.0400
6.8360
3.0180
--
Interest Expense
-18.5430
36.1360
75.7740
68.2980
--
Net Interest Income
48.8480
28.9040
-68.9380
-65.2800
--
EBIT
-1,299.1090
-1,745.4080
-1,863.5470
-1,558.2590
-431.6320
EBITDA
-1,297.7780
-1,679.3150
-1,724.0130
-1,465.4250
-431.6320
Reconciled Cost of Revenue
14.6670
1.8020
164.4270
--
--
Reconciled Depreciation
1.3310
66.0930
139.5340
92.8340
--
Net Income from Continuing Operation Net Minority Interest
-1,377.3260
-1,781.5440
-1,939.3210
-1,626.5570
-431.6320
Total Unusual Items Excluding Goodwill
-953.7040
-978.2750
-53.7410
6.0000
--
Total Unusual Items
-953.7040
-978.2750
-53.7410
6.0000
--
Normalized EBITDA
-344.0740
-701.0400
-1,670.2720
-1,471.4250
-431.6320
6/30/2020 - 11/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BLAB.CN Britannia Life Sciences Inc.
0.0600
0.00%
PLUR.TA Pluri Inc.
1,847.00
-3.45%
AWKN.CN AwaknLifeSc
0.1250
+25.00%
MBX.TO Microbix Biosystems Inc.
0.3350
0.00%
XRTX.V XORTX Therapeutics Inc.
2.6900
+0.75%
COV.V Covalon Technologies Ltd.
3.1400
-1.26%
MSCL.TO Satellos Bioscience Inc.
0.8000
+17.65%
SVA.TO Sernova Corp.
0.2650
0.00%
PLUR Pluri Inc.
4.7500
+2.59%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1450
+3.57%